Saito Yoshiaki

Morita Koji, Gao Yanlin, Saito Yoshiaki, Higashide Tomomi, Kobayashi Akira, Ohkubo Shinji et al.

This study found successful glaucoma filtering blebs formed differently based on limbus- or fornix-based conjunctival flaps, impacting how bleb function is assessed via imaging.

Higashide Tomomi, Murotani Eiji, Saito Yoshiaki, Ohkubo Shinji, Sugiyama Kazuhisa

Studying bevacizumab in neovascular glaucoma, researchers found a 2% risk of central retinal artery occlusion, especially in ocular ischemic syndrome, highlighting the need for careful risk-benefit assessment.

Saito Yoshiaki, Higashide Tomomi, Takeda Hisashi, Murotani Eiji, Ohkubo Shinji, Sugiyama Kazuhisa

This study found that after intravitreal bevacizumab for anterior segment neovascularization, recurrence is common; however, trabeculectomy significantly reduced recurrence, suggesting its clinical benefit for these high-risk patients.

Saito Yoshiaki, Higashide Tomomi, Takeda Hisashi, Ohkubo Shinji, Sugiyama Kazuhisa

Preoperative bevacizumab improved trabeculectomy success and reduced bleeding in neovascular glaucoma, suggesting it's a valuable adjunct to improve surgical outcomes for these complex patients.